AlphaSimPlex Group’s Medicines Co MDCO Stock Holding History

AlphaSimPlex Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,276	Closed	-$668K	–	99
2018 Q1	$668K	Buy	+20,276	New	+$634K	0.39%	83

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

AlphaSimPlex Group's MDCO Position: Q2 2018 in Review

AlphaSimPlex Group sold out of Medicines Co (MDCO) in Q2 2018, closing a stake of 20,276 shares — an estimated $668K sold.

AlphaSimPlex Group first reported a position in MDCO in Q1 2018 and held it in 1 quarter. The position peaked at $668K in Q1 2018. 188 funds tracked by Wall St. Rank hold MDCO as of Q2 2018.

AlphaSimPlex Group reported no remaining Medicines Co position as of Q2 2018 after selling out during the quarter.
AlphaSimPlex Group sold 20,276 Medicines Co shares in Q2 2018, an estimated $668K.
AlphaSimPlex Group first reported a position in Medicines Co in Q1 2018 and held it in 1 quarter.
AlphaSimPlex Group's Medicines Co position peaked at $668K in Q1 2018.
188 funds tracked by Wall St. Rank held Medicines Co as of Q2 2018.

Based on AlphaSimPlex Group's 13F filing for Q2 2018, filed 14 Aug 2018.